Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
26 /100
MEDIUM RISK
Score updated Oct 27, 2026

TRVI — Trevi Therapeutics, Inc. Dilution Risk Tracker

Track TRVI dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track TRVI — Get alerts when the score changes →

As of October 27, 2026, Trevi Therapeutics, Inc. (TRVI) has a DilutionWatch DilutionScore of 26/100, rated MEDIUM dilution risk. Trevi Therapeutics, Inc. has a market capitalization of $1.86B, 142.48M shares outstanding, 201 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
52
💰 Cash Runway
0
📊 Float Risk
7
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for TRVI.
🔔 Track TRVI — Get forecast alerts →

Market Data

Market Cap$1.86B
Shares Outstanding142.48M
Float117.83M
Cash$318.87M
DebtN/A
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore26/100DilutionWatch score record
Shares Outstanding142.48MVerified float table or market cache
Public Float117.83MVerified float table or market cache
Market Cap$1.86BMarket data cache
Cash Runway78.4 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 7.

Recent SEC source mix: 4 5, XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

TRVI SEC Filing Activity — Last 12 Months

Shares outstanding reported by TRVI on the cover page of its latest 10-K/10-Q: 142.48M as of July 31, 2026.

DilutionWatch recorded no shelf, registration or prospectus documents for TRVI in the last 12 months. Full filing list on SEC EDGAR →

FormWhat it isFilingsMost recent
8-Kcurrent report (material event)3Aug 06, 2026
3initial insider ownership9Sep 17, 2026

Institutional Holdings

QoQ: ↑ 16.0% shares (2026Q1 vs prior)
201 institutional holders · 154.93M shares
#1 NEA Management Company, LLC 13.22M shares
#2 BlackRock, Inc. 10.24M shares
#3 Vivo Capital, LLC 10.19M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest16.01M
Days to Cover4.5
% of Float13.6%
FINRA data as of Oct 15, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-03-17
xbrl XBRL CONVERTIBLE 2021-03-25
4 INSIDER TRANSACTION 2026-02-20
4 INSIDER TRANSACTION 2026-02-20
4 INSIDER TRANSACTION 2026-02-20
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual TRVI Dilution Snapshot

Trevi Therapeutics, Inc. (TRVI) has a DilutionScore of 26/100, rated Medium dilution risk. Score date: October 27, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

TRVI's DilutionScore is currently 26/100 (Medium risk), with 1 score change tracked over 89 days. The score improved from 14/100 (Low risk).

Period Score Risk Level Duration
Oct 10 – Oct 27, 202626/100MEDIUM18 days
Jul 30 – Oct 09, 202614/100LOW71 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

TRVI shares outstanding have increased 10.7% from 128.23M (Mar 2026) to 141.98M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 18, 2026141.98M117.83M▲ 0.27%
May 10, 2026141.98M117.51M▲ 0.27%
May 08, 2026141.98M117.19M▲ 10.58%
Apr 20, 2026128.40M105.98M▲ 1.98%
Mar 21, 2026128.40M103.93M▲ 0.03%
Mar 20, 2026128.23M103.90M▲ 0.13%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track TRVI Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment TRVI files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking TRVI — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,566+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for TRVI
TRVI FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.